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ABSTRACT

We propose a resource allocation model for the management of the fund for the screening
and treatment of women infected by Chlamydia trachomatis and Neisseria gonorrhoeae .
The goal is to maximize the number of infected women cured of Chlamydia trachomatis and
Neisseria gonorrhoeae infections. The population going for screening is divided into groups
by ages and races. The group number is dynamic. Different groups have different infection
rates. There are four possible test assays and four possible treatments. We employed a
two-phase algorithm to solve the problem. The first phase is small so an exhaustive method
is applied, while the second phase is transformed to a knapsack problem and a dynamic
programming method is applied.
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CHAPTER 1
INTRODUCTION – PRELIMINARIES

Chlamydia trachomatis (CT) and Neisseria gonorrhoeae (GC) rank as the two most commonly reported sexually transmitted diseases (STDs) in the United States [1]. In 2002, more
than 834,500 cases of CT were reported to the Centers for Disease Control and Prevention
(CDC) out of an estimated 3 million cases [2] . The number of GC infections reported
for the same year was over 351,800. Untreated CT and GC infections may result in pelvic
inflammatory disease (PID), ectopic pregnancy and infertility, with the healthcare cost of
untreated CT and GC infections and their attributable PID estimated at over $2 billion
annually [3, 4].
The CDC through its Division of Sexually Transmitted Disease(DSTD), and in coolaborative efforts with health-care providers has been continually working to evolve effective
ways to manange and control CT and GC infections. At the Health Services Research and
Evaluation Branch(HSREB) of DSTD, there is ongoing research to find effective ways to
deploy the limited resources at the disposal of family planning and DSTD clinics to combat
the spread of CT and GC. The preventive Health Amendments of 1992 provided $8.3 million
in fiscal year 1994 for the prevention of infertility associated primarily with CT. As of December 2000, all 50 states in the US and District of Columbia had enacted laws requiring the
reporting of CT infections. CT-related activities authorized by legislation include detection,
treatment, follow-up, and referral services for at-risk and their sex-partners. In 1994, the
direct anuual cost resulting form CT cases and its attributable PID was estimated to be $
2 billion by one study. Moreover, up to 70% of CT infections and 50% of GC infections are
asymptomatic [5, 6, 7, 8].
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1.1

Background of the Problem

Although annual screnning for CT and GC is recommended for sexually active adolescents
and young women, many publicly funded clinic programs may not have sufficient budgets
to screen all eligible women with the most effective tests and to offer all eligible women
a more expensive, single-dose treatment that optimizes compliance. As a result, the best
strategy to detect and treat the most infections is through universal screening of at-risk
populations. However, most public health programs or clinics may not have the resources
to screen all patients with the most effective test and treatment. Thus, to effectively use
limited resources, CT and GC control programs usually provide selective screening based
on some defined guidelines. The CDC recommends that all sexually active women below
the age of 25 year be screened at least once annually for CT [9]. Unlike in the case of
CT, there is no established recommendation to screen for GC, see U.S. Preventive Services
Task Force(USPSTF) recommendations: there is a recommendation for at risk women. The
highly non-uniform demographical distribution of the infection may be among the reasons
why no such recommendation exists. In the absence of established GC screening recommendations for the general population, control programs have used several approaches, including
universal screening, selective screening, routine dual treatment, and reflex testing, in which
CT positive patients are tested for GC.
Recent studies have reported that up to 45% of family planning and STD clinic female
patients that are infected with GC are also infected with CT [10]. Such high coinfection rates
may seem to justify the CDC’s longstanding recommendation that presumptive treatment
for CT be given to women who test positive for GC in populations where the coinfection of
rate is > 20% [11].
To best use their limited resources, many clinics have conducted studies to design ef-
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fective screening criteria for their CT/GC control programs. However, for CT/GC control
programs, identifying which subpopulations to screen for chlamydial and/or gonorrheal infections is just one part of a complicated problem. The availability of several testing technologies
with varying performances and costs present a challenge for program managers when making
decisions about selecting test assays. Newer diagnostic tests that are less intrusive and more
sensitive offer increased opportunities for screening, but at a greater cost. One question that
many clinic managers face is, whether it is better to use a more sensitive and expensive test
to screen fewer patients, or rather use a relatively cheaper and less sensitive test to screen
a greater number of patients. To further complicate the situation, test manufacturers market combination tests or bundled tests at prices that are more lucrative than the price of a
single-pathogen test. This situation encourages the testing for GC even when its prevalence
in the population is extremely low.
Many studies have examined the cost-effectiveness of screening for CT and/or GC, as
well as the comparative cost-effectiveness of using different testing technologies. However,
because the parameters that influence the screening outcomes are many and may vary considerably, a resource allocation model can be used improve the outcomes for each particular
setting [12].
Because CT infection is a strong predictor of GC infection and the control programs
and resources for the two infections are often integrated, we expanded Tao et al’s resource
allocation model to include gonorrhoeae. Our objective was to develop a model that found
the combination of screening coverage, testing technology and treatment that would maximize the number of CT and/or GC infections cured under a fixed program budget. We also
wanted to analyze the threshold prevalence at which screening for CT or GC is cost effective.
This thesis presents a binary linear programming model that determines the optimal
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combination of screening and test selection, and treatment for controlling CT and GC infections in asymptomatic women for a fixed budget program. The next chapter discusses
binary programming methods used in decision making problem formulations. In Chapter 3,
the models to solve the problem are developed based upon related work done by Tao et al,
and Chapter 4 discusses the results obtained from the model implementation.

CHAPTER 2
LINEAR PROGRAMMING

The flow of resources in a production process or any quantitative process involves complex
inter-relationships among numerous activities. Although differences may exist between the
processes involved, as well as between the goals to be achieved, in many cases there are major
similarities in the operations of seemingly very different systems. In order to analyze such
systems, the working parts (such as capital, raw materials, labor, etc.) of the system have
to be first identified, and the goal or objective to be achieved (for example minimization of
cost or maximization of profit) has to be set. A mathematical model may then be found for
the system. A computational scheme is then developed to determine the best schedule of
action among several alternatives to achieve the objective. The designing of such schemes
is called mathematical modeling. If a system to be analyzed can be represented by (or
approximated to) a model consisting of linear inequalities and its objective also expressible
as a minimization or maximization of a linear expression, the analysis of the system is called
linear programming.
Linear programming (LP), as a mathematical and operations research technique, is
widely used in making quantitative decisions in the management and administration of military, governmental, commercial and industrial systems. Linear programming has been used
in several large-scale problems, often resulting in important interventions and huge costsavings.
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2.1

The Linear Programming Model

Generally, a linear programming application involves the problem of finding a combination
of different types of activities that efficiently exploits some limited available resources. The
solution to a linear programming problem reduces to finding an optimal value (which may be
a minimum or a maximum, depending on the problem) of a linear function of several variables
(called the objective function) subject to a set of constraints. Let xj (for j = 1, 2, ..., n) be
level of activity j and cj be the increase in the objective function Z = f (x) that would result
from a unit increase in level of activityj. Let bi be the amount of resource i (for i = 1, 2, ..., m)
available for allocation to all activities, and aij be the amount of resource i consumed by
each unit of activity j. A linear programming model may then be formulated as
Maximize
Z = c1 x1 + c2 x2 + ... + cn xn ,
Subject to
a11 xl + a12 x2 + ... + aln xn < b1
a2l x1 + a22 x2 + ... + a2n xn < b2
..
.
aml x1 + am2 x2 + ... + amn xn < bm
and
x1 > 0, x2 > 0, . . . , xn > 0
The levels of activities xi , are called the decision variables. The restrictions on the
decisions variables, expressed as inequalities in the ’Subject to’ part of the formulation are
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called constraints. The last set of inequalities, xj ≥ 0 are called nonnegativity constraints.

Other Forms of LP Formulation
The general LP model we have discussed may be written compactly as
maximize{Z = cx|Ax ≤ b, x ≥ 0},
where A is a matrix, b and x are column vectors, and c is a row vector. However, there are
many other problems for which their LP formulations are different from the general model
described. Other possible forms of LP problem formulations are obtained by making the
following modifications:
(1) Minimizing rather than maximizing the objective function:
minimize Z =

n
X

cj x j

j=1

(2)Functional constraints with ≥ inequality:
ai1 x1 + ai2 x2 + ... + ain xn ≥ bi for some values of i.
(3) Functional constraints in equation form:
ai1 x1 + ai2 x2 + ... + ain xn = bi for some values of i.
(4) Making some of the decision variables unrestricted:

xj unrestricted in sign for some values of j.
Any LP problem that mixes some of the above forms can be reduced to the standard form
we described earlier by some algebraic manipulations. For example, a minimization problem
may be transformed into a maximization problem by multiplying the objective function by -1.
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Solving LP Problems
According to Encyclopedia Britannica, applications of the method of linear programming were first seriously attempted in the late 1930’s by Leonid Kantorovich and Wassily
Leontiefin the areas of manufacturing schedules. However, little recognition was given to
their work at that time. It was after the World War Π, during which linear programming
was used extensively to deal with the problem of transportation scheduling and allocation
of resources under many constraints that the subject gained acceptability. Then, in 1947
George Dantzig developed the simplex method, which greatly simplified the solution of linear
programming problems, giving further impetus to the subject.
Since the 1950s, linear programming has experienced a remarkable growth and is used
in many applications, which would have been thought to be too complex and enormous to
deal with. It is in this same period that the computer industry has made extraordinary
developments. The link between the developments made in operations research (and for
that matter, linear programming) and the advances made in the computer industry cannot
be over emphasized. The development of high-speed microprocessors and data-processing
techniques has brought the breakthrough that operations research needed. It must be noted,
however, that the computational resources needed to solve a linear programming problem
can be very high and so many problems may still be computationally infeasible.
Two families of solution techniques are widely used in many of today’s linear programming software. Both techniques visit a progressively improving series of trial solutions, until
a solution is reached that satisfies the conditions for an optimum. The simplex method
approach, developed in 1947 by George Dantzig, visits ”basic” solutions computed by fixing
enough of the variables at their bounds to reduce the constraints Ax = b to a square system,
which can be solved for unique values of the remaining variables. Basic solutions represent
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extreme boundary points of the feasible region defined by Ax = b, x > 0, and the simplex
method can be viewed as moving from one such point to another along the edges of the
boundary. Barrier or interior-point methods, by contrast, visit points within the interior of
the feasible region. The focus of this thesis is to formulate binary programming models for
the problem introduced in chapter one, and therefore the details of these solution methods
will not be discussed.
There are several computer packages available today that incorporate different variants
of the simplex method and interior-point algorithms to solve linear programming problems.
These computer packages may be put into two groups: solvers and modeling languages.
Solvers are essentially computer implementations of one or more of the available linear programming algorithms. Several vendors market multi-purpose solvers that can be applied
to a wide array of linear programming and other optimization problems. Also, specialized
solvers may also be developed for particular problems, and may not even be applicable to
other similar problems. Some of the most popular solvers available today include CPLEX,
FortMP, LDSfDO (Linear INteractive Discrete Optimizer), LPSolve, Solver DLL, and XA,
Xpress [16].
Large-scale linear programming models can contain hundreds of constraints, and these
constraints are often expressed with indexes and summation notation. Before a solver can
be called to solve the problem, these many constraints must be read individually. Modeling
languages provide the convenient environment for formulating linear programming models
in an easy and efficient way, allowing the use of several arithmetic operators, vectors and
summations. They offer several features for model management, data import and export,
report generation, and translation of the user-entered model into algorithmic code usable
by an available solver. Modeling languages require at 1east one solver, and many vendors
offer compatibility with several solvers. Examples of modeling languages include, AIMMS,
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AMPL, GAMS, MPL, and LINGO [16].

2.2

Assumptions of Linear Programming

Representing real-world problems by mathematical models often require the imposition of
several assumptions since mathematical models often describe ideal, unattainable situations.
Therefore, to apply a linear programming formulation to a problem, the fundamental assumptions of proportionality, additivity, divisibility, and certainty have to been met. These
assumptions are at the core of the linear programming formulation itself, and must be satisfied together with other assumptions that may be made for a particular problem.
Proportionality is an assumption that the contribution of each activity to the objective
function Z is proportional to the level of the activity xj . Also, the contribution of each
activity in the functional constraint equation is proportional to the level of activity the xj .
As a result of this proportionality assumption, the objective function and the functional
constraints are all first-degree equations in the variable Xj .
The additivity assumption requires that every function in the linear programming model
is the sum of individual contributions of the respective activities. Therefore, cross-product
terms (involving the product of two or more variables) are excluded by the additivity assumption. The additivity, together with the proportionality assumption, ensures that all
functions in the model are linear combinations of the decision variables.
The divisibility assumption allows the decision variables to be continuous. They can
take on integer values as well as fractional values. This assumption, as will be discussed
later, may be deliberately violated in certain situations.
Lastly, the certainty assumption allows us to assume that all the parameters of model,
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namely, the coefficients of the objective function, the coefficients of the functional constraints,
and the amount of available resources, are known constants. In real-world problems, however,
model parameters are not always precisely known and maybe subject to other uncontrollable
factors.
Due in part to the certainty assumption, it is a well-acknowledged fact that the exact
solution obtained from one implementation of an optimization model is not conclusive. After
an optimal solution is found, sensitivity analysis is conducted to identify the parameters that
influence the optimal solution. By performing sensitivity analysis, we are able to determine
ranges for parameters for which the optimal solution stays the same.

2.3

Integer Programming

The divisibility assumption allows solutions to the LP problem to take non-integer values.
In practice, however, there are many problems for which the solution makes sense only if the
decision variables have integer values. Typical examples involve locating production facilities
at different sites, and assigning individuals to operate equipment. If a 1inear programming
problem is further constrained for some or all of its decision variables to be integer values, the
resulting formulation is called integer linear programming, (commonly referred to as integer
programming). When some, but not all of the decision variables are restricted to integers,
the problem is called mixed integer programming(MIP).In the case where all the decision
variables are restricted to integers, the formulation is called a pure integer programming.
Linear and integer programming have proved valuable for modeling many and diverse
types of problems in planning, routing, scheduling, assignment and design. Industries that
make use of linear programming and its extensions include transportation, energy, telecommunications, and manufacturing of many kinds.
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2.4

Binary Integer Programming

When decision variables of an integer programming problem are restricted to just two integer
values, 0 or 1, the problem becomes a binary integer programming problem. The use of
binary integers allows many special formulation techniques to manipulate both the decision
variables and the constraint equations. Integer programming problems such as the fixedcharge network flow problem and the famous traveling salesman problem are often expressed
in terms of binary variables. The fixed-charge network problem modifies the minimum-cost
network flow paradigm by adding a term to the cost, where the binary variable is set to 1 if
an arc carries a nonzero flow; it is set to zero otherwise.
Many times other variables besides the decision variables are introduced in the model to
help formulate the objective function or the constraint equations. Such variables, which are
not part of the original problem, are called auxiliary variables. We consider some problem
formulation possibilities with binary variables and auxiliary variables next.

Either-Or Decision Variables
Problems that involve ”yes-or-no decisions” or ”on-or-off” variables can be modeled by
allowing the variables to assume a binary value, 0 or 1. Thus the jth variable would be
represented by Xj defined as

xj =




1, if decision j is yes,


0, if decsion j is no.

Constraint Selection
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Sometimes a model will include a set of m possible constraints for which any k of them
must hold. The model then chooses the combination of k constraints that optimizes the
objective function.
We denote the m possible constraints by the following functions:

f1 (x1 , x2 , ...., xn ) ≤ b1
f2 (x1 , x2 , ...., xn ) ≤ b2
..
.
fm (x1 , x2 , ..., xn ) ≤ bm
A set of m auxiliary binary variables y1 , y2 , ..., ym are introduced into the constraints to
obtain this formulation:
f1 (x1 , x2 , ...., xn ) ≤ b1 + M y1
f2 (x1 , x2 , ...., xn ) ≤ b2 + M y2
..
.
fm (x1 , x2 , ..., xn ) ≤ bm + M ym
m
X

yi = m − k,

i−1

and yi is a binary variable, for i = 1, 2, ..., m,
where the auxiliary variable yt is defined as:



1, if constraint i holds,
yi =


0, if decision i does not hold.
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and M is an extremely large (within the context of the problem) positive number. If
yi , = 0, then M yi = 0, which reduces the augmented constraint to its original form. But,
when yi = 1, then M yt makes the right-hand-side of the constraint inequality extremely large
(unbounded within the context of the problem). Therefore, the corresponding constraint is
effectively eliminated from the model.
Either-Or Constraints
A specific application to the constraint selection technique described above involves two
constraints from which only one must hold. This requirement can be stated as
either
f1 (x1 , x2 , ...., xn ) ≤ b1
or
f2 (x1 , x2 , ...., xn ) ≤ b2 .
The model formulation that achieves the desired effect is
f1 (x1 , x2 , ...., xn ) ≤ b1 + M y1
f2 (x1 , x2 , ...., xn ) ≤ b2 + M y2
and y is a binary varible.

CHAPTER 3
MODELS

3.1

Description of the model

We propse a model to use binary variables in a mixed-integer model to find optimal strategies.
The object is to maximize the number of infected patients cured from the clinic perspective
under a fixed program budget.
Based on CT and GC infection and coinfection rates, we analyzed the following five
scenarios that differed by the pathogens tested for, and/or whether or not presumptive
treatment is done: (1) screen for CT and treat those who test positive; (2) screen for GC
and treat those who test positive; (3) screen for both CT and GC and treat those who test
positive; (4) Screen for CT and treat those with positive CT results for both CT and GC;(5)
Screen for GC and treat those with positive GC results for both GC and CT. For each of
the five screening and treatment combinations, the model analyzed screening coverage for
twelve population-groups divided by 3 age groups: (1) less than 20 years; (2) 20-24 years;
and (3) more than 24 years; 4 race groups: (1) White; (2) Black; (3) Hispanic; (4)Other. six
tests, and two treatments for each infection. The tests differed in performance on sensitivity
and specificity or whether they were capable of detecting a single pathogen or both.
Currently, CDC mainly uses two pathogen-specific tests each for CT and GC and two
combination tests for both CT and GC at the same time. For CT-specific tests, the commonly used nucleic acid hybridization test (Pace 2; Gen-Probe, San Diego, CA) and a
nucleic acid amplification test (strand displacement amplification [SDA]; BDProbeTec, BD
Biosciences, Sparks, MD) were modeled. For GC-specific tests, we modeled culture and a
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nucleic acid amplification test (polymerase chain reaction [PCR]; Roche Diagnostic Systems,
Branchburg, NJ). The two combination tests we modeled were the nucleic acid hybridization
test, PACE 2C manufactured by Gen-Probe, and a bundled nucleic acid amplification test
BDProbeTec CT/GC test by Becton Dickinson. We modeled two commonly-used CDCrecommended treatments for CT infection, (azithromycin and doxycycline). For GC infection, we modeled ceftriaxone and cefpodoxime. The use of cefpdoxime to treat for GC is
not yet recommended by CDC. But with reported increasing resistance to fluoroquinolones
and the discontinued production of cefixime (the only CDC-recommended oral treatment
besides fluoroquinolones). some health departments have suggested the use cefpodoxime as
an alternative oral treatment [17].
Without lose of generality, we address some extensions to the tests and treatments. We
assumed that there were r screenings for CT, s screenings for GC, t combination tests for
both CT and GC; and there are u treatments for CT, v treatments for GC. Those extentions
would make this model more flexible and practical.
A number of simplifying assumptions were made in the model. First, we assumed that
all women who visited the family planning clinic and were infected with CT and/or GC had
no symptoms of infection. This simplify assumption was based on data from Philadelphia’s
publicty funded family planning program showing that <10% of women have symptoms of
CT infection. Second, we assume all women who tested positive for CT infection and/or
GC would be treated. Third, we considered strategies that could allow the screening and
treatment of some or all population groups. Fourth, we assumed that either all or none of
the women in each age-group will be screened. Fifth, we assumed that the return rate for
treatment for women who tested positive for CT and/or GC is uniform for all age groups.
Sixth, we assumed that the same test and treatment were offered to each visiting population
group. Seventh, we assumed that no patient received more than one test or treatment for
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CT and/or GC.

3.2

Data used in the model

We used data from published literature and from expert opinion from public health researchers where data was unavailable or insufficient(table 1). Group-specific infection rates
of CT and GC were based on data from Philadelphia family planning clinics from 1996-1997,
and from the CDC 2002 Sexually Transmitted Disease Surveillance Report [18]. Groupspecific coinfection rates were based on a recent CDC study that examined GC infection
rates and coinfection rates with CT [19]. Test costs included the cost of the test kits,
reagents and labor time for collection and processing. We did not include the cost for a
pelvic examination because such an examination is often conducted for reasons other than
CT or GC screening. The cost of a pelvic examination was thus not considered as a direct
screening-specific cost.
All costs published in previous literature were adjusted to 2003 US dollars using the
medical component of the Consumer Price Index.
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Table 3.1: Variables used in the optimal resource allocation model

Variable

CT

GC

baseline(range)

baseline(range)

Among women aged <20 y

0.013-0.025

0.006-0.008

Among women aged 20-24 y

0.013-0.025

0.006-0.008

Among women aged >24 y

0.013-0.025

0.006-0.008

Among women aged <20 y

0.1-0.125

0.012-0.081

Among women aged 20-24 y

0.1-0.125

0.012-0.081

Among women aged >24 y

0.1-0.125

0.012-0.081

Among women aged <20 y

0.023-0.030

0.004-0.020

Among women aged 20-24 y

0.023-0.030

0.004-0.020

Among women aged >24 y

0.023-0.030

0.004-0.030

Among women aged <20 y

0.023-0.030

0.004-0.020

Among women aged 20-24 y

0.023-0.030

0.004-0.020

Among women aged >24 y

0.023-0.030

0.004-0.030

Pace 2 CT

0.780

N/A∗

BDProbeTecCT

0.928

N/A∗

Prevalence of infection
white

black

hispanic

others

Sensitivity of tests

Reference
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Culture

N/A∗

0.850

PCR

N/A∗

0.900

Pace 2C Combo

0.78

0.810

BDProbeTec CT/GC

0.928

0.966

Pace 2 CT

0.993

N/A∗

BDProbeTecCT

0.981

N/A∗

Culture

N/A∗

0.995

PCR

N/A∗

0.990

Pace 2C Combo

0.993

0.993

BDProbeTec CT/GC

0.993

0.995

8.03

N/A∗

BDProbeTecCT

9.42

N/A∗

Culture

N/A∗

4.20

PCR

N/A∗

9.26

Pace 2C Combo

4.31 + 8.03

4.31+7.51

BDProbeTec CT/GC

7.82

7.82

Doxycycline

0.900

N/A∗

Azithomycin

0.965

N/A∗

Ceftriaxone

N/A∗

0.977

Ciprofloxacin

N/A∗

0.972

Cefpodoxime

N/A∗

0.965

4.00

N/A∗

Specificity of CT tests

Cost of tests

Pace 2 CT

Effectiveness of treatment

Cost of treatment
Doxycycline
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Azithomycin

9.50

N/A∗

Ceftriaxone

N/A∗

15.37

Ciprofloxacin

N/A∗

5.27

Cefpodoxime

N/A∗

7.32

PID from untreated infection

0.21

0.21

Patient’s return for treatment

0.81

0.81

Probabilites

Cost per case of PID

1434(1434-4131)

Cost of treatment

14.00
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3.3

The mathematical model

To find an optimal strategy that maximizes the number of infected patients cured, we need to
determinize which population group to screen, which testing technologies to use, and which
treatments to use. We used a mixed-integer program to determin the optimal strategy. In
the mixed-integer program, three sets of indexed binary variables were created: (1) xi is a
binary variable for population group, xi = 1 if group i is selected and 0 otherwise. (2) yj
is a binary variable for screening, yj = 1 if screening method j is selected and 0 otherwise;
(3) xkl for presumptive treatment. The first index i corresponds to population-group(i=1,2,
. . .,12); the index j corresponds to screen methods (i=1,2, . . .,6); the index k corresponds to
treatment for CT(k=1,2); The index l corresponds to treatment for GC(l=1,2), the notations
and variables defined as below:

Notation:
• let Sct1 denotes the screening assay 1 for CT, Sct2 denotes the screening assay 2 for
CT
• let Sgc1 denotes the screening assay 1 for GC, Sgc2 denotes the screening assay 2 for
GC
• let Scombo1 denotes the screening assay 1 for both CT and GC, Scombo2 denotes the
screening assay 2 for both CT and GC

The fifth index m corresponds to treatment, also there exists three conditions:
• let T ct1 denotes treatment 1 for CT, let T ct2 denotes treatment 2 for CT
• let T gc1 denotes treatment 1 for GC, let T gc2 denotes treatment 2 for GC
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Variables:
1. There are 12 population groups and set xi = 1 if group i is selected and 0 otherwise.
2. There are 6 screening methods: Sct1 (1), Sct2 (2), Sgc1 (3), Sgc2(4), Scomb1 (5),
Scomb2 (6).
Let yj = 1 is screening j is selected and 0 otherwise.
3. There are 8 treatment methods: T ct1 (1,0), T ct2 (2,0), T gc1 (0,1), T gc2 (0,2), T ctk +
T gcl = (k, l). for k = 1, 2 and l = 1, 2.
Let xkl = 1 if treatment (k, l) is selected and 0 otherwise.
Target Functions: the number of unit of diseases that would be cured
For j = 1, 2, means to use the screen assay 1 for CT or screen assay 2 for CT to screen
all the population groups let
Curedijkl = P rev(i, 1) · senj · Ef f (k)
+ P rev(i, 1) · senj · CoP rev(1, 2) · Sign(l) · Ef f (l)
+ (1 − prev(i, 1)) · (1 − Spej ) · CoN onP rev(1, 2) · sign(l) · Ef f (l)
Where CoN onP rev(1, 2) =

prev(1,2)−P rev(i,1)·CoP rev(1,2)
.
1−P rev(i,1)

Because
P opi · P rev(i, 2) = P opi · P rev(i, 1) · Copre(1, 2)
+ P opi · (1 − P rev(i, 1)) · CoN onP rev(1, 2)
then one can get
CoN onP rev(1, 2) =

prev(1, 2) − P rev(i, 1) · CoP rev(1, 2)
1 − P rev(i, 1)
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For j = 3, 4, means to use the screen assay 1 for GC or screen assay 2 for GC to screen
the population groups we define Curedijkl similarly. For j = 3, 4, let
Curedijkl = P rev(i, 2) · senj · Ef f (l)
+ P rev(i, 1) · senj · CoP rev(2, 1) · Sign(k) · Ef f (k)
+ (1 − prev(i, 2)) · (1 − Spej ) · CoN onP rev(2, 1) · sign(k) · Ef f (k)

where
CoN onP rev(2, 1) =

prev(2, 1) − P rev(i, 2) · CoP rev(2, 1)
1 − P rev(i, 2)

For j = 5, 6, means to use the combination screen assay1 or combination screen assay2
to screen both CT and GC, let

Curedijkl = P rev(i, 1) · Sen(j, 1) · Ef f (k) +
+ P rev(i, 2) · Sen(j, 2) · Ef f (l)

Let
T Cured =

X
ijkl

Cost Functions:
For j = 1, 2, let

P opi · ReP rob(i, j) · Curedijkl · xi · yj · zk,l
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Costijkl = P opi (BaseCostj + V isitingCost)
+ P opi (P rev(i, 1) · Senj + (1 − P rev(i, 1))(1 − Spej ))
·

(DrugCost(k))ReP rob(i, 1) +

+ P opi (P roev(i, 1)Senj + (1 − P rev(i, 1))(1 − Spej )) ·
sign(l) · DrugCost(l) · ReP rob(i, 1)

For j = 3, 4, we define Costijkl similarly.
Costijkl = P opi (BaseCostj + V isitingCost)
+ P opi (P rev(i, 2) · Senj + (1 − P rev(i, 2))(1 − Spej ))
·

DrugCost(l)ReP rob(i, 2) +

+ P opi (P roev(i, 2)Senj + (1 − P rev(i, 2))(1 − Spej )) ·
sign(k) · DrugCost(k) · ReP rob(i, 2)

For j = 6, let

Costijkl = P opi (BaseCost + V isitingCost)
+ P opi (P rev(i, 1)Sen(j, 1) + (1 − P rev(i, 1))(1 − Spe(j, 1)))
·DrugCost(k) · ReP rob(i, 1)
+ P opi (P rev(i, 2)Sen(j, 2) + (1 − P rev(i, 2))(1 − Spe(j, 2)))
·DrugCost(l) · ReP rob(i, 2)

For j = 5, this is a special case, because this screen has additional cost, which used to
identify what infection(s) the patients have been infected. We need to introduce some new
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notation here

• let BaseSen(1, 0) denote the base sensitivity for CT
• let BaseSen(0, 1) denote the base sensitivity for GC
• let BaseSen(1, 1) denote the base sensitivity for testing the people who has both CT
and GC

For j = 5, the cost is:
Costijkl = P opi · {P rev(i, 1) · (1 − Coprev(1, 2)) · BaseSen(1, 0)
+ P rev(i, 1) · Coprev(1.2) · BaseSen(1, 1)
+ P rev(i, 2) · (1 − Coprev(2, 1)) · BaseSen(0, 1)
+ [(1 − P rev(i, 1)) − (1 − prev(i, 1)) · CoN oprev(1, 2)] · (1 − BaseSpe)}
·

(AddCost(1) + AddCost(2))

+ P opi (P rev(i, 1)Sen(j, 1) + (1 − P rev(i, 1))(1 − Spe(j, 1)))
·DrugCost(k) · ReP rob(i, 1)
+ P opi (P rev(i, 2)Sen(j, 2) + (1 − P rev(i, 2))(1 − Spe(j, 2)))
·DrugCost(l) · ReP rob(i, 2)

Therefore the problem is
max T Cured =

P

i,j,k,l

Curedijkl xi yj zl,m .

subject to

X
ijkl

Costijk2 xi yj zl,m ≤ Budget.
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6
X

yj ≤ 1,

j=1

X

zkl = 1.

k,l

As we can see, this model could be caterogrize into the 0 − 1 Knapsack problem(KP
problem) for fixed j, k and l. The definition of 0-1 KP problem is: given a set of n items
and a knapsack , with
pj = prof it of item j
,
wj = weight of item j
,
c = capacity of item j
,
select a subset of the items so as to

maximize z=

subject to:

Pn

j=1

Pn

j=1

p j xj

xj ≤ c

xj = 0 or 1, j ∈ N = 1, . . . , n;

where
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xj =




1, if item j is selected,


0, otherwise.

In the fifties, Bellman’s dynamic programming theory produced the first algorithm to
exactly solve the 0-1 KP problem. In the sixties, the dynamic programming approach to
the KP and other KP-type problems was deeply investigated by Gilmore and Gomory. In
1967, Kolesar experimented with the branck-and-bound algorithm for the problem. In the
seventies, the branch-and-bound algorithm was further developed, proving to be the only
method capable of solving problems with a high number of variables.
In order to solve our practical problem, we developed a two-step algorithm, combining
exhaustive and dynamic programming algorithms.

3.4

The Algorithm

In the seven assumptions provided previously, there is a very strong one that simplifies our
model a lot. We assume that all population groups should take the same test and same
treatment(s). It means for all population groups which are selected to attend the test and
treatment(s), the test and treatment(s) should be all the same to every group.
For Screening and treatments, there are r test assays for CT, s for GC, t assays for
combination tests. For treatments, there are u assays for treatments of CT, v assays for
treatments for GC. Hence, there are uv combinations to choose one from the treatments of CT
and one from the treatments of GC. The total combinations of CT screening and treatments
is: r(u + uv). For the same reason, the combination of GC screening and treatments is
: s(v + uv). If the population groups use combination tests for both CT and GC, the
combination numbers are tuv. so the total combinations is :
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r(u + uv) + s(v + uv) + tuv
= ru + sv + uv(r + s + t)

Obviously, the complexity of the exhaustive algorithm in this case is in term of r,s,u,t.
Considering the population group, there are 12 groups in our model. If each group
chooses to go for test or not to go, then, this is a knapsack problem. The number of the
population group’s choices is 212 . If there are more population groups, the combinations
would increase exponentially. And the Knapsack problem is a NP-Complete, there is no
known polynomial-time alogrithm for this type of question. Therefore, we need to use
dynamic programming or a branch and bound algorithm to deal with it with the hope of
reducing the complexity. Here we decide to put dynamic programming into use because the
number variables in our model is not that high.
Therefore, the model could be split up into two parts, accordingly, We bring up a
two-period algorithm to process it.
1). At the first period, we exhaust all the combinations of test and the treatments.
The total combinations is ru + sv + uv(r + s + t). The polynomial-time problem makes the
exhaustive algorithm reasonable.
2). At the second period, we use dynamic programming algorithm to find out which
group(s) should be enforced test and treatment(s). The Knapsack problem is a NP-complete
problem. The complexity is non-polynomial.
The knapsack problem can be solved in pseudo-polynomial time using dynamic programming. The following depicts a dynamic programming solution for the unbounded knapsack
problem.
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Let the costs be c1 , . . . cn and the corresponding values v1 , . . . vn . We wish to maximize
total value subject to the constraint that total cost is less than C. Then for each i ≤ C,
define A(i) to be the maximum value that can be attained with total cost less than or equal
to i, clearly, A(C) is the solution of the problem.
Define the A(i) recursively as follows:

• A(0) = 0
• A(i) = max{vj + A(i − cj ) for all cj ≤ i}

Here the maximum of the empty set is taken to be zero. Tabulating the results from A(0)
up through A(C) gives the solution. Since the calculation of each A(i) involves examining
n items (all of which have been previously computed), and there are C values of A(i) to
calculate, the running time of the dynamic programming solution is thus O(nC).
In this paper, we performed a two period model of resources allocation model on a
web-based application. The front-end webpage is written by Java Sever Page(JSP), which in
charge of inputing data and output result. The back-end algorithm is written in Java. The
user will get the data from the webpage and feedback an optimization allocation method.
This does not contradict the fact that the knapsack problem is NP-complete, since C,
unlike n, is not polynomial in the length of the input to the problem. The length of the
input to the problem is proportional to the number of bits in C, not to C itself.
A similar dynamic programming solution for the 0-1 knapsack problem also runs in
pseudo-polynomial time[20]. As above, let the costs be c1 , . . . , cn and the corresponding
values v1 , . . . , vn . We wish to maximize total value subject to the constraint that total cost
is less than C. Define a recursive function, A(i, j) to be the maximum value that can be
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attained with cost less than or equal to j using items up to i.

• A(0, j) = 0
• A(i, 0) = 0
• A(i, j) = A(i − 1, j)if ci > j
• A(i, j) = max(A(i − 1, j), vi + A(i − 1, j − ci ) if ci ≤ j)

The solution can then be found by calculating A(n, C). To do this efficiently we can use
a table to store previous computations. This solution will therefore run in O(nC) time and
O(nC) space, though with some slight modifications we can reduce the space complexity to
O(C).

CHAPTER 4
RESULTS AND DISCUSSIONS

4.1

Results

Table 4.1: Optimal Strategy

total

budget

population

test

treatment

total

budget

per patient

group

19,000

19.0

2

CULTURE

Doxy+Cip

72

19,100

19.1

2

CULTURE

Azi+Cip

73

19,680

19.68

2

CULTURE

Azi+Cef

74

20,140

20.14

2

CULTURE

Azi+Cef

74

20,150

21.25

2

APTIMACT/GC Doxy+Cip

105

20,180

20.18

6

APTIMACT/GC

155

40,050

20.02

2,9

APTIMACT/GC Doxy+Cip

164

40,500

20.25

2,6

APTIMACT/GC Doxy+Cip

254

43,500

21.75

2,6

APTIMACT/GC

Azi+Cef

265

205,000

20.05

1,2,3,4

APTIMACT/GC

Azi+Cef

cured person

Azi+Cef

5,6,7,8

539

10,11
300,000

25,00

1-12

APTIMACT/GC

Azi+Cef

579

we applied our model to a hypothetical cohort of 1000 asymptomatic women evenly distributed among the population groups considered. The strategies that maximized the num-
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ber of cures at different total budgets and per-patient budgets are presented in Table 2. In
the Table 2 above, the index number 1-12 of the population groups stands for the group with
different age and races, as the Table3 shows:
From the the Table 2 we can know, for example, under the total budget of $19,000,
only population group 2 would choose to take part in the test and treatment. Then the perpatient budget is $19.00. Use Culture for the test assay, Doxy and Cip for the treatments.
The number of cured people would be 72. Population group 2 stands for the group of black
people with the age less than 20 years old. The infection rate of CT and GC ranges from 0.10.125 and 0.012 - 0.081 respectively, which are much higher than other groups. Therefore,
when the budget is not enough, this group should get priority to be tested and treated. In
addition, this group’s infection rate of CT is much higher than the rate of GC, the optimal
strategy is to choose test assays for CT rather than GC or the combined test because of the
limited budget.
All of the optimal strategies listed in Table 2 could be classifed into two groups. When
the total budget is limited, the best strategy is to choose the less expensive Culture as the
test assay. When the budget is enough, we should use the expensive combined test-APTIMA
CT/GC as the test assay.
Frome Table 2, one could see the overall trend is that if the total budget increases the
total number of cured persons also increases. But when you considering the per patient
budget, the situation becomes a little bit more complicated. With the increasing of the toal
budget, the per patient budget goes up and downs. For example, when the total budget
ranges from $125,000 to $165,000, the per patient budget drops from $20.8 to $18.30, but
the total cured persons increases tremendously from 427 to 488.
From the Table 2, one could see the treatments would be Azi and Cef in most of the
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occasions. In fact, treatments would not play as an important role in the budget planning.
We can imagine that only a very small part of the whole population (sometimes the part is
less than 1%) is the positive patients which need to be treated. Therefore the population
to go for treatment would be very small. As a result, the money spent on treatment drugs
would be very small. The key factor that would influence the budget planning tremendously
is the test assay. All the population groups would go for screen, and everybody would be
screened with a certain assay. Most of the budget would be invested in the test. Hence the
decision of which test assay should be used is the critical factor.
From all the strategies listed in Table 2, we could not draw an conclusion about which
one is better, to use a more sensitive and expensive test to screen fewer patients, or rather
to use a relatively cheaper and less sensitive test to screen a greater number of patients. It
depends on the data of the budget, infection rate and all kinds of characteristcs of the test
assays and treatments. Based on our current data, we could say that to use less sensitive
test to screen a great number of patients should be better when the total budget is limited.
This mathematical model was formulated by a web-based application. The front-end
web page is written by Jave serve page. The back-end program is written by Java language.
They are connected by Javabean. The whole framework of this web-application is based on
Model-Controller-View(MVC) pattern, using MySQL as the database to store the data.
We deploy the whole application on the sun-blade-100 workstation. The website’s address:
http://131.96.241.29:8080/wx/project2.html. And the source code is attached in
the appendix.
Table 4.2: population group

white

black

hispanic others
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<20 years old

1

2

3

4

20 − 24 years old

5

6

7

8

> 24 years old

9

10

11

12

4.2

Future Work

Although the models discussed in this thesis provide useful tools for clinicians in allocating resources for controlling C. trachomatis(CT) and Neisseria gonorrhoeae(GC) infections,
they have several limitations and hence there still exist several opportunities to advance this
study. Some of these limitations and opportunities for further work are discussed below.
Possible improvements
1. In our current web application, we make the categorization of the population group configurable. One can randomly divide the population into different groups by age and race.
This makes the webpage very flexible and could meet the practical requirments of the user.
With the exception for the population group, other parameters such like infections, screen
assays, and treatments are all static. For example, one can not add or delete an infections
or several infections one the webpage. The assays for screening and drugs for treatments are
all constant. One could not add or delete them. Hence this web-based application is not
expandable and could not satisfy user’s practical requirments. The next step should be to
make all the parameters such like infections, screen assays, and treatments drugs dynamic
and configurable. Considering many branches of CDC would use this application for decision
making later, each user would have its own profile for population groups, infections, screens
and treatments. Besides making all of those parameters configurable, we should go further
to adopt a database to store all user’s profile data, which would be great convience for all
the users.
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2. We use the dynamic programming as the background algorithm. Compared with exhaustive mothod, dynamic programming saves time by the sacrifice of space. When the size of the
problem becomes bigger, the memeory would be consumed very quickly or even the program
could break down soon. As an improvement, the Branch and Bound algorithm is a good
choice. For a given problem space an efficient division will divide the solution space into a
small set containing high value (or low cost) solutions to be examined more closely and a
larger set of their opposites (those to be ignored). If a partial solution cannot improve on the
best, it is abandoned. Therefore, the computer is not necessary to store all data of combinations of population groups, screens and treatments. This saves space and time. Furthermore,
This method naturally lends itself for parallel and distributed implementations. We could
even implement the parallel computing and distributed computing. By parallel computing,
a computing process would be divided into several threads,each thread would compute a
subregions of the problem, hence a lot of time could be saved. By distributed computing,
we could deploy the application onto several servers and each the server would collabrate for
computation. The computing speed of the program would increase tremendously.
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APPENDIX

Code: Knapasack Algorithm

import javax.swing.UIManager;

/**
* @author Wei Xin.
*/
public class Knapsack2 {
static int v=0;
/**
* Calculates the optimal vector.
* @param w are the weights.
* @param p are the prices.
* @param n is the number of items.
* @param c is the capacity.
* @param m are the coefficients of the constraints.
* @param x is the resulting vector.
*/
public static void knapsack2(int[] w, int[] p, int n,
int c, int[][] m, boolean[] x)
{
int i,j,k;

39
for(i=0;i<=n;i++)
{
m[i][0] = 0;
x[i] = false;
}
for(i=0;i<=c;i++){
m[0][i]=0;
}

for(i=1;i<=n;i++)
{
for(j=1;j<=c;j++)
{
m[i][j]=m[i-1][j];
if((j>=w[i-1])&&((m[i-1][j-w[i-1]]+p[i-1])>m[i-1][j]))
m[i][j]=m[i-1][j-w[i-1]]+p[i-1];
}
}
j=c;
for(i=n;i>0;i--)
{
if(m[i][j]>m[i-1][j])
{
x[i-1]=true; j=j-w[i-1];
}
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}
v=m[n][c];
}
/**
* Get the result.
* @return the result.
*/
public int get_result()
{
return v;
}
/**
* Prints the result.
*/
public static void printinfo()
{
System.out.println(v);
}
/**
* This is the main procedure.
* @param args are the arguments.
*/
public static void main(String[] args)
{
int[] ww = {2,2,3,5,4};
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int[] pp = {6,3,5,4,6};
boolean[] xx = new boolean[6];
int[][] mm = new int[11][11];
int i;
knapsack2(ww,pp,5,10,mm, xx);
printinfo();
for(i=0;i<5;i++)
System.out.println(xx[i]);

}
}

Code: calculate the coeffcients

package user7;
import java.text.*;
import java.util.*;

public class Coef{
int pop;

//population

double upre;

//upper prevalence

double sen;

//sensitivity

double spe;

//specificity

double bcost;

//basecost

double acost;

//additional cost

42
double dcost;

//drug cost

double vcost;

//visit cost

double eff;

//effectiveness

double rp;

//return probability

double copre;

//coprevelance

double budget;

//budget

double scured;
double mcured;
double tcost;
double drcost;
double mcost;

public Coef(int popi, double uprei, double seni, double spei, double bcosti, double acos

double dcosti, double vcosti, double effi, double rpi, double copr
{
pop

= popi;

upre

= uprei;

sen

= seni;

spe

= spei;

bcost = bcosti;
acost = acosti;
dcost = dcosti;
vcost = vcosti;
eff

= effi;
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rp

= rpi;

copre = coprei;
}
public void set_Scured()
{
scured = pop*upre*sen*eff*rp;

//calculate the CTcured & GCcured

}
public void set_Mcured()
{
mcured = pop*upre*sen*copre*eff*rp;

//CTinGCcured and GCinCTcured

}
public void set_Tcost()
{
tcost = pop*(bcost+(upre*sen*acost));

//CTtestcost and GCtestcost

}
public void set_Drcost()
{
drcost = pop*(upre*sen+(1-upre)*(1-spe))*(dcost+vcost)*rp;

//CTdrug cost and GCdrugcost

}
public void set_Mcost()
{
mcost = pop*dcost*rp*(upre*sen*copre+(1-upre)*(1-spe));
}
public double get_Scured()
{

//CTinGCcost and GCinCTcost
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return scured;
}
public double get_Mcured()
{
return mcured;
}
public double get_Tcost()
{
return tcost;
}
public double get_Drcost()
{
return drcost;
}
public double get_Mcost()
{
return mcost;
}
public void printInfo()
{
this.set_Scured();
this.set_Mcured();
this.set_Tcost();
this.set_Drcost();
this.set_Mcost();
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DecimalFormat df=new DecimalFormat("$#,###.##");
System.out.println("singlecured: \t" +df.format(scured));
System.out.println("mixedcured: \t" +df.format(mcured));
System.out.println("testcost: \t" +df.format(tcost));
System.out.println("drugcost: \t" +df.format(drcost));
System.out.println("mcost: \t" +df.format(mcost));
}
public static void main(String[] args)
{

Coef coef1 = new Coef(1000, 0.125, 0.78, 0.993, 4.31, 8.03, 9.5, 14, 0.965, 0.81, 0.45);
coef1.printInfo();
}
}

Code: Main Program(just part of them)

<%@ page import="user7.Coef" %>

<%@ page import="user6.Coefpage2" %>

<%@ page import="user8.Knapsack2" %>

<html>
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<title>the setup of self-defined class and object</title>
<style type="text/css">
<!-.style3 {
font-size: 16px;
font-weight: bold;
color: #FF0000;
}
-->
</style>
<body>

<%

<%
Coefpage2 coef2 = new Coefpage2(vcost1, rp1, budget1);
coef2.setPop();
coef2.getPop();

%>

<%
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double CTcured[][][] = new double[12][2][2];
double GCinCTcured[][][] = new double[12][2][2];
double CTtestcost[][][] = new double[12][2][2];
double CTdrugcost[][][] = new double[12][2][2];
double GCinCTcost[][][] = new double[12][2][2];

double GCcured[][][] = new double[12][2][2];
double CTinGCcured[][][] = new double[12][2][2];
double GCtestcost[][][] = new double[12][2][2];
double GCdrugcost[][][] = new double[12][2][2];
double CTinGCcost[][][] = new double[12][2][2];

double ComboCTcured[][][] = new double[12][2][2];
double ComboGCinCTcured[][][] = new double[12][2][2];
double ComboCTtestcost[][][] = new double[12][2][2];
double ComboCTdrugcost[][][] = new double[12][2][2];
double ComboGCinCTcost[][][] = new double[12][2][2];

double ComboGCcured[][][] = new double[12][2][2];
double ComboCTinGCcured[][][] = new double[12][2][2];
double ComboGCtestcost[][][] = new double[12][2][2];
double ComboGCdrugcost[][][] = new double[12][2][2];
double ComboCTinGCcost[][][] = new double[12][2][2];

int[][] TotalCTcured = new int[12][12];
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int[][] TotalCTcost = new int[12][12];
int[][] TotalGCcured = new int[12][12];
int[][] TotalGCcost = new int[12][12];
int[][] TotalCombocured = new int[12][8];
int[][] TotalCombocost = new int[12][8];

int[] Finalcured = new int[32];
int[] Finalcost = new int[32];
int j=0;

int MaxCured = 0;

int

gs1, gs2;

int i, k, l, r,

n;

n = r = 0;

gs1 = gs2 = 0;

for (i = 0; i < 12; i++)
{
j = 0;
for (k = 0; k < 2; k++)
for (l = 0; l < 2; l++) {
Coef coefct = new Coef(pop[i], cupre[i], ctsen[k], ctspe[k],
ctbcost[k], ctacost[k],
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ctdrcost[l], vcost1, cteff[l], rp1, copre[0]);
coefct.set_Scured();
coefct.set_Mcured();
coefct.set_Tcost();
coefct.set_Drcost();
coefct.set_Mcost();

CTcured[i][k][l] = coefct.get_Scured();
GCinCTcured[i][k][l] = coefct.get_Mcured();
CTtestcost[i][k][l] = coefct.get_Tcost();
CTdrugcost[i][k][l] = coefct.get_Drcost();
GCinCTcost[i][k][l] = coefct.get_Mcost();

Coef coefgc = new Coef(pop[i], gupre[i], gcsen[k], gcspe[k],
gcbcost[k], gcacost[k],
gcdrcost[l], vcost1, gceff[l], rp1, copre[1]);
coefgc.set_Scured();
coefgc.set_Mcured();
coefgc.set_Tcost();
coefgc.set_Drcost();
coefgc.set_Mcost();

GCcured[i][k][l] = coefgc.get_Scured();
CTinGCcured[i][k][l] = coefgc.get_Mcured();
GCtestcost[i][k][l] = coefgc.get_Tcost();
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GCdrugcost[i][k][l] = coefgc.get_Drcost();
CTinGCcost[i][k][l] = coefgc.get_Mcost();

TotalCTcured[i][j] = (int) CTcured[i][k][l] +
(int) GCinCTcured[i][k][l];
TotalCTcost[i][j] = (int) CTtestcost[i][k][l] +
(int) CTdrugcost[i][k][l] + (int) GCinCTcost[i][k][l];
TotalGCcured[i][j] = (int) GCcured[i][k][l] +
(int) CTinGCcured[i][k][l];
TotalGCcost[i][j] = (int)GCtestcost[i][k][l] +
(int) GCdrugcost[i][k][l] + (int) CTinGCcost[i][k][l];
j++;
}
}

for (i = 0; i < 12; i++)
{ j=4;
for (k = 0; k < 2; k++)
for (l = 0; l < 2; l++)
for (r = 0; r < 2; r++) {
TotalCTcured[i][j] = (int) CTcured[i][k][l] +
(int) GCinCTcured[i][k][l]+(int) GCcured[i][k][r] +
(int) CTinGCcured[i][k][r];
TotalCTcost[i][j] = (int)CTtestcost[i][k][l]+
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(int) CTdrugcost[i][k][l]
+(int) GCinCTcost[i][k][l]+(int) GCdrugcost[i][k][r]
+(int) CTinGCcost[i][k][r];
TotalGCcured[i][j] = (int) GCcured[i][k][l] +
(int) CTinGCcured[i][k][l]+(int) CTcured[i][k][r] +
(int) GCinCTcured[i][k][r];
TotalGCcost[i][j] =TotalCTcost[i][j] = (int)GCtestcost[i][k][l]+
(int)GCdrugcost[i][k][l]
+(int) CTinGCcost[i][k][l]+(int)CTdrugcost[i][k][r]
+(int)GCinCTcost[i][k][r];

j++;

}
}

for (i = 0; i < 12; i++) //calculate the combo
{ j=0;
for (k = 0; k < 2; k++)
for (l = 0; l < 2; l++)
for (r = 0; r < 2; r++) {
Coef coefcomboct = new Coef(pop[i], cupre[i], combo_ctsen[k],
combo_ctspe[k], combo_ctbcost[k],
combo_ctacost[k],
ctdrcost[l], vcost1, cteff[l], rp1,
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copre[0]);
coefcomboct.set_Scured();
coefcomboct.set_Mcured();
coefcomboct.set_Tcost(); //the CT coeff in Combo
coefcomboct.set_Drcost();
coefcomboct.set_Mcost();

ComboCTcured[i][k][l] = coefcomboct.get_Scured();
ComboGCinCTcured[i][k][l] = coefcomboct.get_Mcured();
ComboCTtestcost[i][k][l] = coefcomboct.get_Tcost();
ComboCTdrugcost[i][k][l] = coefcomboct.get_Drcost();
ComboGCinCTcost[i][k][l] = coefcomboct.get_Mcost();

Coef coefcombogc = new Coef(pop[i], gupre[i], combo_gcsen[k],
combo_gcspe[k], combo_gcbcost[k],
combo_gcacost[k],
gcdrcost[l], vcost1, gceff[l], rp1,
copre[1]);
coefcombogc.set_Scured();
coefcombogc.set_Mcured();
coefcombogc.set_Tcost(); //the GC coeff in Combo
coefcombogc.set_Drcost();
coefcombogc.set_Mcost();

ComboGCcured[i][k][l] = coefcombogc.get_Scured();
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ComboCTinGCcured[i][k][l] = coefcombogc.get_Mcured();
ComboGCtestcost[i][k][l] = coefcombogc.get_Tcost();
ComboGCdrugcost[i][k][l] = coefcombogc.get_Drcost();
ComboCTinGCcost[i][k][l] = coefcombogc.get_Mcost();

TotalCombocured[i][j] = (int)ComboCTcured[i][k][l]
+(int)ComboGCinCTcured[i][k][l]
+(int)ComboGCcured[i][k][r]
+(int)ComboCTinGCcured[i][k][r];
TotalCombocost[i][j]= (int)ComboCTtestcost[i][k][l]
+ (int)ComboCTdrugcost[i][k][l] + (int)ComboGCinCTcost[i][k][l]
+ (int)ComboGCtestcost[i][k][l]+ (int)ComboGCdrugcost[i][k][r]
+ (int)ComboCTinGCcost[i][k][r];

j++;

}
}

%>

<%
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for(j=0;j<12;j++)
{
n = 0;
{
for (i = 0; i < 12; i++) {
Finalcured[n] = TotalCTcured[i][j];
Finalcost[n] = TotalCTcost[i][j];
n++;
}

int[][] mm = new int[13][ (int)budget1 + 1];
boolean[] x = new boolean[13];
Knapsack2 kp = new Knapsack2();
kp.knapsack2(Finalcost, Finalcured, 12, (int)budget1, mm, x);
gs1=kp.get_result();
//kp.printinfo();

if (MaxCured < gs1) {
MaxCured = gs1;
r=j;
gs2=1;
}

}
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}

for(j=0;j<12;j++)
{
n = 0;
{
for (i = 0; i < 12; i++) {
Finalcured[n] = TotalGCcured[i][j];
Finalcost[n] = TotalGCcost[i][j];
n++;
}

int[][] mm = new int[13][ (int)budget1 + 1];
boolean[] x = new boolean[13];
Knapsack2 kp = new Knapsack2();
kp.knapsack2(Finalcost, Finalcured, 12, (int)budget1, mm, x);
gs1=kp.get_result();
//kp.printinfo();

if (MaxCured < gs1) {
MaxCured = gs1;
r=j;
gs2=2;
}
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}
}

for(j=0;j<8;j++)
{
n = 0;
{
for (i = 0; i < 12; i++) {
Finalcured[n] = TotalCombocured[i][j];
Finalcost[n] = TotalCombocost[i][j];
n++;
}

int[][] mm = new int[13][ (int)budget1 + 1];
boolean[] x = new boolean[13];
Knapsack2 kp = new Knapsack2();
kp.knapsack2(Finalcost, Finalcured, 12, (int)budget1, mm, x);
gs1=kp.get_result();
//kp.printinfo();

if (MaxCured < gs1) {
MaxCured = gs1;
r=j;
gs2=3;
}
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}
}

%>

</body>
</html>

